KTRA - Kintara Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

15.09M

Cash

2.61M

Avg Qtr Burn

-2.966M

Short % of Float

0.56%

Insider Ownership

4.17%

Institutional Own.

3.29%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
VAL-083 Details Glioblastoma, Cancer Big Mover™ Suspected Mover™ Susp. Mover™	Phase 2/3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.